ADVFN
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
INmune Bio Inc

INmune Bio Inc (INMB)

2.42
0.18
(8.04%)
Closed July 19 4:00PM
2.3598
-0.0602
(-2.49%)
After Hours: 7:54PM

INmune Bio Inc (INMB) Quote

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.3598
( 5.35% )
Bid
2.33
Ask
2.40
Volume
1,976,482
2.2401 Day's Range 2.48
1.89 52 Week Range 11.64
Market Cap
Previous Close
2.24
Open
2.26
Last Trade
63
@
2.36
Last Trade Time
Financial Volume
$ 4,617,759
VWAP
2.3364
Average Volume (3m)
2,718,772
Shares Outstanding
23,210,377
Dividend Yield
-
PE Ratio
-1.34
Earnings Per Share (EPS)
-1.81
Revenue
14k
Net Profit
-42.08M

About INmune Bio Inc

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others. INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Carson City, Nevada, USA
Founded
-
INmune Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INMB. The last closing price for INmune Bio was $2.24. Over the last year, INmune Bio shares have traded in a share price range of $ 1.89 to $ 11.64.

INmune Bio currently has 23,210,377 shares outstanding. The market capitalization of INmune Bio is $51.99 million. INmune Bio has a price to earnings ratio (PE ratio) of -1.34.

INmune Bio (INMB) Options Flow Summary

Overall Flow

Bearish

Net Premium

-1M

Calls / Puts

0.00%

Buys / Sells

750.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

INMB Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.13986.29729729732.222.462.0416842602.23569507CS
4-4.9402-67.67397260277.311.641.8973124313.89505608CS
12-5.6002-70.35427135687.9611.641.8927187724.26996815CS
26-4.2052-64.05483625296.56511.641.8914480124.76801146CS
52-6.6602-73.83813747239.0211.641.898337184.91990835CS
156-8.0002-77.22200772210.3614.741.893243625.55912682CS
260-9.0502-79.318141980711.4130.371.892973908.9368899CS

INMB - Frequently Asked Questions (FAQ)

What is the current INmune Bio share price?
The current share price of INmune Bio is $ 2.3598
How many INmune Bio shares are in issue?
INmune Bio has 23,210,377 shares in issue
What is the market cap of INmune Bio?
The market capitalisation of INmune Bio is USD 51.99M
What is the 1 year trading range for INmune Bio share price?
INmune Bio has traded in the range of $ 1.89 to $ 11.64 during the past year
What is the PE ratio of INmune Bio?
The price to earnings ratio of INmune Bio is -1.34
What is the cash to sales ratio of INmune Bio?
The cash to sales ratio of INmune Bio is 4.05k
What is the reporting currency for INmune Bio?
INmune Bio reports financial results in USD
What is the latest annual turnover for INmune Bio?
The latest annual turnover of INmune Bio is USD 14k
What is the latest annual profit for INmune Bio?
The latest annual profit of INmune Bio is USD -42.08M
What is the registered address of INmune Bio?
The registered address for INmune Bio is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701
Which industry sector does INmune Bio operate in?
INmune Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NEXMNexMetals Mining Corporation
$ 6.50
(173.11%)
103.24k
TELOTelomir Pharmaceuticals Inc
$ 2.295
(89.67%)
135.81M
IXHLIncannex Healthcare Ltd
$ 0.6001
(62.15%)
491.07M
CYCCCyclacel Pharmaceuticals Inc
$ 13.07
(58.81%)
22.37M
BZAIBlaize Holdings Inc
$ 4.80
(58.42%)
73.13M
PTNMPitanium Ltd
$ 2.18
(-67.02%)
4.62M
YHCLQR House Inc
$ 2.38
(-63.77%)
9.93M
KMRKK Tech Solultions Company Ltd
$ 2.45
(-44.94%)
12.06M
SRPTSarepta Therapeutics Inc New
$ 14.07
(-35.96%)
78.44M
CLSDClearside Biomedical Inc
$ 0.4076
(-32.27%)
3.66M
OPENOpendoor Technologies Inc
$ 2.25
(36.36%)
589.71M
IXHLIncannex Healthcare Ltd
$ 0.6001
(62.15%)
491.41M
BTOGBit Origin Ltd
$ 0.7675
(21.63%)
362.58M
LCIDLucid Group Inc
$ 3.035
(-2.72%)
294.46M
NVDANVIDIA Corporation
$ 172.41
(-0.34%)
146.48M

INMB Discussion

View Posts
jondoeuk jondoeuk 3 weeks ago
The trial missed its primary endpoint. The trial also missed its secondary endpoints. I doubt they will find a partner to advance it.
πŸ‘οΈ0
tredenwater2 tredenwater2 3 weeks ago
Perhaps INMB wojld have benefitted from using the FDA’s open label adaptive ph 2 cross over trial like Anavex did. We are clearly on a firm foundation of efficacy because if the ph 2a as we near approval in the EU.

On a financing note, yes I also highly appreciate Dr. Missling’s clear savvy moves to minimally allow dilution to Anavex shareholders on the way to approval…..inhouse!

Management of INMB should be ashamed for securing a financing deal ahead of releasing bad news. Did the funding source know the data and shorted against the box? Smells very bad!
👍️ 2
tschussmann1 tschussmann1 3 weeks ago
Every Alzheimer's trial fail makes me appreciate AVXL that much more...
👍️ 2
tschussmann1 tschussmann1 3 weeks ago
Yes indeed! Fortunately it was a small stake...not much effect on the portfolio.
πŸ‘οΈ0
retireat40 retireat40 3 weeks ago
Looks like a terrible decision 
πŸ‘οΈ0
tschussmann1 tschussmann1 3 weeks ago
The low 5's after the 20% share increase priced at 6.30 provided a nice entry point...and not long to wait to see it it was a good decision.
👍️ 2
murocman murocman 3 weeks ago
Happens all the time.  Not a surprise.
πŸ‘οΈ0
retireat40 retireat40 3 weeks ago
$5's
πŸ‘οΈ0
retireat40 retireat40 3 weeks ago
Then they dropped an offering at $6.30. What a shit move. 
πŸ‘οΈ0
rbl100 rbl100 3 weeks ago
OFFERING - @ $6.30 per share.....
πŸ‘οΈ0
tw0122 tw0122 3 weeks ago
$13s 
πŸ‘οΈ0
GhosTraderX GhosTraderX 3 weeks ago
INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
https://ih.advfn.com/stock-market/NASDAQ/inmune-bio-INMB/stock-news/96320079/inmune-bio-inc-to-announce-top-line-results-from
GhosT
👍️ 4
jondoeuk jondoeuk 1 month ago
An update https://www.globenewswire.com/news-release/2025/06/02/3091859/0/en/Syncromune-Inc-Presents-Positive-Results-from-SYNC-T-Therapy-SV-102-Phase-1-Metastatic-Prostate-Cancer-Trial-at-ASCO-2025.html

https://www.globenewswire.com/news-release/2025/05/30/3091053/0/en/Syncromune-Announces-First-Patient-Dosed-in-LEGION-100-Phase-2a-Trial-of-SYNC-T-Therapy-SV-102-for-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer.html
πŸ‘οΈ0
jondoeuk jondoeuk 4 months ago
Apples to oranges, but this is the kind of data you want to see https://syncromune.com/wp-content/uploads/2024/04/SYNC-T-AACR-Website.pdf
πŸ‘οΈ0
jondoeuk jondoeuk 4 months ago
So no scans, waterfall or swimmer plots! Doesn't look like there is any single-agent activity https://archive.fast-edgar.com/20250304/AD29K22CLM22K282222G22Y2M9BIZ2224272/ea023314201ex99-1_inmune.htm

Drugs with no single-agent activity rarely, if ever improve outcomes in randomised and controlled trials when used alone or in combination.
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 7 months ago
ELAB Partnership
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
INMB under $5
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
INMB new 52 week low
πŸ‘οΈ0
tw0122 tw0122 9 months ago
Study Demonstrate XPro converts microglia from a demyelinating cell to a remyelinating cell.Multi-year study published has implications for many CNS diseases including Alzheimer's.
πŸ‘οΈ0
tw0122 tw0122 9 months ago
INMB 5.27 something brewing over here in some
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
INMB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INMB under $10
πŸ‘οΈ0
jondoeuk jondoeuk 1 year ago
''The third patient for the INKmune™ AML program in UK and EU has been enrolled and subsequent to their completion of follow-up, the company will wind down the AML program to focus resources on the prostate-cancer program and other solid tumors.'' https://www.globenewswire.com/news-release/2024/03/28/2854450/0/en/INmune-Bio-Inc-Announces-Year-End-2023-Results-and-Provides-a-Q4-Business-Update.html

Good luck to them in solid tumours!
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
INMB indeed it did
πŸ‘οΈ0
DollarDan DollarDan 2 years ago
Starting to move up!
πŸ‘οΈ0
jondoeuk jondoeuk 2 years ago
Did the trial in ovarian ever start?
πŸ‘οΈ0
derkampfer derkampfer 2 years ago
Don't need to convince us. We are fully invested and believers in both the INKmune NK cell therapy for certain cancers as well as XPro for AD and possibly others neuro inflammation sensitive diseases, including Parkinson’s.

Two robust programs and each have multi-billion value potential based on TAM

Exciting times.

GLTA longs
πŸ‘οΈ0
jondoeuk jondoeuk 2 years ago
Sure, it is early days in patients, but the data has yet to be https://ashpublications.org/blood/article/140/Supplement%201/4590/492304/In-Vivo-Generation-of-Memory-like-NK-Cells-for-the

Keep in mind that the ORR (focusing on R/R AML) is ~30-35% across multiple trials using adoptive transfer of non-engineered NK cells.
πŸ‘οΈ0
dennisdave dennisdave 3 years ago
blocked
πŸ‘οΈ0
conix conix 3 years ago
INMB chart....finally a reversal?

πŸ‘οΈ0
conix conix 4 years ago
INMB Chart

πŸ‘οΈ0
derkampfer derkampfer 4 years ago
XPro news also impressive. Data very.

β€œThe data from this Phase I trial show that XPro decreases biomarkers of neuroinflammation and nerve cell death while improving biomarkers of neurorepair in patients with AD,” stated RJ Tesi, M.D., CEO of INmune Bio
πŸ‘οΈ0
derkampfer derkampfer 4 years ago
INKmune news was impressive. Albeit one patient dosed additional eight (8) in line. No toxicity. Ovarian cancer on deck.

https://finance.yahoo.com/news/inmune-bio-inc-announces-biomarker-200000970.html
πŸ‘οΈ0
spartex spartex 4 years ago
Almost, $13 to $10 is a downward slope. but maybe over time things will be reversed??
πŸ‘οΈ0
spartex spartex 4 years ago
Booooooom? More like, BurP! LOL. Still researching INMB
πŸ‘οΈ0
derkampfer derkampfer 4 years ago
New run began today. Deeper dive Alzheimer’s drug they’re developing is phenomenal. Early studies some patients seeing reversed effects.

Unbelievable.
πŸ‘οΈ0
Fress Fress 4 years ago
$INMB just ran from $2.00 to 30.00 congrats to the longs. what a beast of a stock.



*INmune Bio shares are trading higher after the company announced results for its Phase 1B study of XPro1595. The results show a decrease in biomarkers of neuroinflammation across multiple measures and assays, including cerebrospinal fluid and MRI.



$PDSB CD8+ (killer) T-cells. T cell platform is next.


$INMB
πŸ‘οΈ0
john sezso john sezso 5 years ago
I need a bigger rake to scoop up all this cash trade....
πŸ‘οΈ0
john sezso john sezso 5 years ago
Still crickets here....
πŸ‘οΈ0
john sezso john sezso 5 years ago
Good enough for Harry Reid it's good enough for me. I'm in for the 50's
πŸ‘οΈ0
byrdiesoccer byrdiesoccer 5 years ago
They are speaking with Roth Capital right now
πŸ‘οΈ0
akamaii akamaii 5 years ago
Shorts bring this to 8 I wanna buy
πŸ‘οΈ0
l2 hunter l2 hunter 5 years ago
INMB CHART >>>> going in position before test $25 next days again. after $25 blue skies... $13-$15 range a gift imho think will run big next days

πŸ‘οΈ0
starkd748 starkd748 5 years ago
Wow that public offering is peanuts ...Kaboom here tomorrow
πŸ‘οΈ0
l2 hunter l2 hunter 5 years ago
INMB ready to test $24 high from last week next days.. strong technical setting now.
πŸ‘οΈ0
l2 hunter l2 hunter 5 years ago
INMB NEWS OUT!!!!!!!!! BOOOOOOOOOOOOOOOOOOOOMMMMMMMMMMMMMMMMMMMMMMMM
πŸ‘οΈ0
l2 hunter l2 hunter 5 years ago
INMB CHART >>> Strong setting for next big wave above $20 next week if News update drop imho >>>>>

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $INMB Video Chart 07-14-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
dinogreeves dinogreeves 5 years ago
Looks like a strong close finally.
πŸ‘οΈ0
$treet $inatra $treet $inatra 5 years ago
INMB monster pop https://finance.yahoo.com/news/inmune-bio-inc-announces-interim-201600548.html
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock